Back
Summit Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison
Sell
36
SMMT
Summit Therapeutics
Last Price:
$18.37
Seasonality Move:
15.86%
Sell
20
NONOF
Novo Nordisk AS
Last Price:
$87.12
Seasonality Move:
8.64%
Sell
36
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy, Sell or Hold?
-
The current Summit Therapeutics [SMMT] share price is $17.85. The Score for SMMT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
SMMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $85.90. The Score for NONOF is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $17.85Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing slight buying pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.90Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 45.55 | Sell |
Chaikin Money Flow: | 403159 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.75 - 18.91) | Sell |
Bollinger Bands (100): | (14.56 - 22.7) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.16 | Sell |
Relative Strength Index (14 RSI): | 29.72 | Sell |
Chaikin Money Flow: | 790 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (92.14 - 112.12) | Sell |
Bollinger Bands (100): | (102.78 - 130.68) | Sell |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.4 | Sell |
20-day SMA: | 18.2 | Sell |
50-day SMA: | 19.18 | Sell |
200-day SMA: | 12.46 | Buy |
8-day EMA: | 18.25 | Sell |
20-day EMA: | 18.4 | Sell |
50-day EMA: | 18.66 | Sell |
200-day EMA: | 13.94 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 88.63 | Sell |
20-day SMA: | 100.89 | Sell |
50-day SMA: | 105.5 | Sell |
200-day SMA: | 124.76 | Sell |
8-day EMA: | 90.07 | Sell |
20-day EMA: | 97.13 | Sell |
50-day EMA: | 105.1 | Sell |
200-day EMA: | 116.2 | Sell |
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.16 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Summit Therapeutics Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |